A carregar...
AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma
Sorafenib is the standard systemic treatment for advanced hepatocellular carcinoma (HCC), and improving its therapeutic effects is crucial for addressing cancer aggression. We previously reported that epalrestat, an aldo-keto reductase 1B10 inhibitor, enhanced sorafenib's inhibitory effects on...
Na minha lista:
| Publicado no: | Int J Med Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294918/ https://ncbi.nlm.nih.gov/pubmed/32547320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.42956 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|